LISTERINE® To Spotlight Clinical Dental Solutions At AEEDC 2025 Amid Rising Oral Health Concerns Across MENA

(MENAFN- Mid-East Info) LISTERINE^®, a flagship oral care brand under Kenvue, announced its upcoming participation in AEEDC 2025, the world's largest dental health conference and exhibition, taking place from 4 to 6 February in Dubai. Trusted by over one billion users across more than 85 countries, LISTERINE^® has been at the forefront of addressing the global burden of periodontal disease-a significant health challenge in the MENA region, where periodontitis accounts for more than one-third of permanent tooth extractions among adults over 40.[1] Research by LISTERINE^® reveals that over 700 bacterial species exist globally, with 200 residing in an individual's mouth[2]. Left unmanaged, these pathogens fuel plaque buildup, gingivitis, and advanced gum disease.

As shifting lifestyles and gaps in preventive care awareness continue to contribute to rising oral health issues in the MENA region, LISTERINE^®'s participation at AEEDC 2025 reaffirms its commitment to addressing local needs. By combining global expertise with insights from regional healthcare professionals, LISTERINE^® aims to advance preventive care and drive better patient outcomes.

At AEEDC 2025, LISTERINE^® will showcase its legacy of research and clinically proven solutions through three dedicated digital kiosks designed to deliver an engaging and educational experience for healthcare professionals. Visitors can test their knowledge with interactive quizzes on oral care best practices and explore touchscreen demonstrations showcasing the efficacy of LISTERINE^® Antiseptic in reducing whole-mouth plaque. In addition, immersive virtual reality (VR) experiences demonstrating how LISTERINE^® helps neutralize harmful bacteria effectively.

“AEEDC 2025 provides an invaluable opportunity to connect with the global dental community and share insights that advance oral health. For over a century, LISTERINE^® has been a trusted partner in oral care, and we are proud to be showcasing our expertise and research-driven solutions that are effectively addressing critical dental health challenges Our mission is to empower practitioners with the tools and knowledge to deliver better patient outcomes and elevate self-care standards globally,” said Rodney Smith, GCC Managing Director, Kenvue.

LISTERINE^® will also host an exclusive workshop on 5 February, dedicated to addressing the global impact of periodontal disease. This session will offer actionable strategies to integrate into daily self-care routines. The workshop will feature insights from Dr. Vinayak Pavate, Periodontist at NMC Hospital, and Dr. Mohammad Naji, a renowned orthodontist and social media influencer.

About Kenvue:

Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including, Aveeno®, Listerine®, Johnson's® Neutrogena® and Nicorette® are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes.

MENAFN04022025005446012082ID1109166717